Obesity-Facilitated Colon Cancer Progression Is Mediated by Increased Diacylglycerol O-Acyltransferases 1 and 2 Levels

Gastroenterology. 2025 Feb;168(2):286-299.e6. doi: 10.1053/j.gastro.2024.09.011. Epub 2024 Sep 18.

Abstract

Background & aims: The obesity epidemic is associated with increased colon cancer progression. As lipid droplets (LDs) fuel tumor growth, we aimed to determine the significance of diacyltransferases (diacylglycerol o-acyltransferases 1 and 2 [DGAT1/2]), responsible for LDs biogenesis, in obesity-mediated colonic tumorigenesis.

Methods: Human colon cancer samples, colon cancer cells, colonospheres, and ApcMin/+ colon cancer mouse model on a high-fat diet were employed. For DGAT1/2 inhibition, enzymatic inhibitors and small interfering RNA were used. Expression, pathways, cell cycle, and growth were assessed. Bioinformatic analyses of CUT&RUN and RNA sequencing data were performed.

Results: DGAT1/2 levels in human colon cancer tissue are significantly elevated with disease severity and obesity (vs normal). Their levels are increased in human colon cancer cells (vs nontransformed) and further enhanced by fatty acids prevalent in obesity; augmented DGAT2 expression is MYC-dependent. Inhibition of DGAT1/2 improves FOXO3 activity by attenuating PI3K, resulting in reduced MYC-dependent DGAT2 expression and accumulation of LDs, suggesting feedback. This inhibition attenuated growth in colon cancer cells and colonospheres via FOXO3/p27kip1 cell cycle arrest and reduced colonic tumors in ApcMin/+ mice on a high-fat diet. Transcriptomic analysis revealed that DGAT1/2 inhibition targeted metabolic and tumorigenic pathways in human colon cancer and colon cancer crypts, stratifying human colon cancer samples from normal. Further analysis revealed that this inhibition is predictive of advanced disease-free state and survival in patients with colon cancer.

Conclusions: This is a novel mechanism of DGAT1/2-dependent metabolic and tumorigenic remodeling in obesity-facilitated colon cancer, providing a platform for future development of effective treatments for patients with colon cancer.

Keywords: Colon Cancer; DGAT1; DGAT2; FOXO3; Lipid Droplets; Obesity.

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Cell Proliferation
  • Colonic Neoplasms* / enzymology
  • Colonic Neoplasms* / etiology
  • Colonic Neoplasms* / genetics
  • Colonic Neoplasms* / metabolism
  • Colonic Neoplasms* / pathology
  • Diacylglycerol O-Acyltransferase* / genetics
  • Diacylglycerol O-Acyltransferase* / metabolism
  • Diet, High-Fat
  • Disease Models, Animal
  • Disease Progression*
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Lipid Droplets / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Obesity* / complications
  • Obesity* / enzymology
  • Obesity* / metabolism
  • Proto-Oncogene Proteins c-myc / genetics
  • Proto-Oncogene Proteins c-myc / metabolism
  • Signal Transduction

Substances

  • Diacylglycerol O-Acyltransferase
  • DGAT1 protein, human
  • DGAT2 protein, human
  • Proto-Oncogene Proteins c-myc
  • DGAT2 protein, mouse